Jiangsu Wuzhong Industrial Co Ltd (600200)

Currency in CNY
0.29
-0.03(-9.38%)
Closed·
Showing Jiangsu Wuzhong historical data. For real-time data please try another search
Fair Value
Day's Range
0.290.32
52 wk Range
0.299.46
Key Statistics
Bid/Ask
0.29 / 0.30
Prev. Close
0.29
Open
0.32
Day's Range
0.29-0.32
52 wk Range
0.29-9.46
Volume
62.5M
Average Volume (3m)
35.55M
1-Year Change
-96.7742%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600200 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Jiangsu Wuzhong Industrial Co Ltd Company Profile

JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti-infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine. The company also offers high-end injection filling products for medical cosmetology. In addition, the company provides abidol hydrochloride tablets, pidotimod oral solution, trimetazidine dihydrochloride tablets, methocarbamol injection, prolonium iodide for injection, carbazochrome sodium sulfonate tablets, lansoprazole for injection, omeprazole sodium for injection, and lianqin pearl dropping pills. It offers its products in various forms, such as hard capsules, granules, tablets, oral solutions, dropping pills, emulsions, large-volume injections, and small-volumes injections, powder injections, freeze-dried powder injections and raw materials, and other dosage forms. The company was founded in 1994 and is based in Suzhou, China.

Employees
1096
Market
China

Compare 600200 to Peers and Sector

Metrics to compare
600200
Peers
Sector
Relationship
P/E Ratio
−3.3x12.3x−0.6x
PEG Ratio
0.050.010.00
Price/Book
0.1x1.9x2.6x
Price / LTM Sales
0.2x3.5x3.4x
Upside (Analyst Target)
-28.3%44.4%
Fair Value Upside
Unlock6.2%6.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 0.00
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
147.84M / --
EPS Revisions
Last 90 days

600200 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.